Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BASILIXIMAB vs BEBTELOVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BASILIXIMAB vs BEBTELOVIMAB: Safety Overview

Metric BASILIXIMAB BEBTELOVIMAB
Total FAERS Reports 6,817 1,383
Deaths Reported 1,507 20
Death Rate 22.1% 1.4%
Hospitalizations 2,802 224
Average Patient Age 44.2 yrs 56.4 yrs
% Female Patients 35.9% 66.9%
Manufacturer Novartis Pharmaceuticals Corporation N/A
Route INTRAVENOUS N/A
Marketing Status Prescription N/A